特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の前立腺癌治療市場:産業分析、規模、シェア、成長、動向、および予測

Prostate Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

発行 Transparency Market Research 商品コード 488786
出版日 ページ情報 英文 206 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.84円で換算しております。
世界の前立腺癌治療市場:産業分析、規模、シェア、成長、動向、および予測 Prostate Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027
出版日: 2019年09月03日 ページ情報: 英文 206 Pages
概要

当レポートは世界の前立腺癌治療薬市場について調査しており、市場機会や動向、成長および阻害要因、療法・流通チャネル・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 序文

  • レポートの範囲および市場のセグメント
  • 調査ハイライト

第2章 前提条件および調査方法

第3章 エグゼクティブサマリー

  • 市場のスナップショット

第4章 市場の概要

  • 治療の概要
  • 市場規模予測
  • 市場の見通し
  • 主要産業イベント
  • パイプライン分析
  • 世界の疾患の有病率および発生率
  • 世界の前立腺がん
  • 臨床段階別

第5章 市場力学

  • 成長要因
  • 阻害要因
  • 市場機会
  • 主な動向

第6章 市場分析:療法別

  • 主な調査結果
  • イントロダクション
  • 市場売上シェア分析
  • 市場分析
    • ホルモン療法
    • 化学療法
    • 生物学的療法
    • 標的療法
  • 市場の魅力分析
  • 主な動向

第7章 市場分析:流通チャネル別

  • 主な調査結果
  • イントロダクション
  • 市場売上シェア分析
  • 市場分析
  • 市場の魅力分析
  • 主な動向

第8章 市場分析:地域別

  • 市場のスナップショット
  • 市場売上シェア分析
  • 市場の予測
  • 市場の魅力分析

第9章 北米

第10章 欧州

第11章 アジア太平洋地域

第12章 ラテンアメリカ

第13章 中東・アフリカ

第14章 競合情勢

  • 市場シェア分析:企業別
  • 競合マトリックス
  • 企業プロファイル
    • Amgen, Inc.
    • Johnson & Johnson (Janssen Biotech, Inc.)
    • Pfizer, Inc.
    • AstraZeneca
    • AbbVie, Inc.
    • Bayer AG
    • Ipsen Group
    • Sanofi
    • Endo Pharmaceuticals, Inc.
    • Dendreon Corporation (Sanpower Group Co. Ltd.)
図表

List of Tables

  • Table 1: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017-2027
  • Table 2: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017-2027
  • Table 3: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017-2027
  • Table 4: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 5: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Region, 2017-2027
  • Table 6: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017-2027
  • Table 7: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017-2027
  • Table 8: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017-2027
  • Table 9: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 10: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2017-2027
  • Table 11: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017-2027
  • Table 12: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017-2027
  • Table 13: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017-2027
  • Table 14: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 15: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 16: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017-2027
  • Table 17: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017-2027
  • Table 18: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017-2027
  • Table 19: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 20: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 21: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017-2027
  • Table 22: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017-2027
  • Table 23: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2017-2027
  • Table 24: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 25: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
  • Table 26: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2017-2027
  • Table 27: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2017-2027
  • Table 28: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy (Therapy), 2017-2027
  • Table 29: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2027
  • Table 30: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027

List of Figures

  • Figure 1: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2017-2027
  • Figure 2: Global Prostate Cancer Therapeutics Market Value Share, by Therapy, 2019 and 2027
  • Figure 3: Global Hormone Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 4: Global Chemotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 5: Global Biologic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 6: Global Targeted Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 7: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019-2027
  • Figure 8: Global Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2019 and 2027
  • Figure 9: Global Hospital Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 10: Global Retail Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 11: Global Online Sales Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 12: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2017-2027
  • Figure 13: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 14: Global Prostate Cancer Therapeutics Market Value Share, by Region, 2019 and 2027
  • Figure 15: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2019-2027
  • Figure 16: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2019-2027
  • Figure 17: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2019-2027
  • Figure 18: North America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2019 and 2027
  • Figure 19: North America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2019 and 2027
  • Figure 20: North America Prostate Cancer Therapeutics Market Value Share, by Country, 2019 and 2027
  • Figure 21: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019-2027
  • Figure 22: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 23: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2019-2027
  • Figure 24: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 25: Europe Prostate Cancer Therapeutics Market Value Share, by Therapy, 2019 and 2027
  • Figure 26: Europe Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2019 and 2027
  • Figure 27: Europe Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2019 and 2027
  • Figure 28: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019-2027
  • Figure 29: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 30: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2019-2027
  • Figure 31: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 32: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Therapy, 2019 and 2027
  • Figure 33: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2019 and 2027
  • Figure 34: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2019 and 2027
  • Figure 35: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019-2027
  • Figure 36: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 37: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2019-2027
  • Figure 38: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 39: Latin America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2019 and 2027
  • Figure 40: Latin America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2019 and 2027
  • Figure 41: Latin America Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2019 and 2027
  • Figure 42: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019-2027
  • Figure 43: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 44: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2019-2027
  • Figure 45: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
  • Figure 46: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Therapy, 2019 and 2027
  • Figure 47: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2019 and 2027
  • Figure 48: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Country/Sub-region, 2019 and 2027
  • Figure 49: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019-2027
  • Figure 50: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • Figure 51: Global Prostate Cancer Therapeutics Market Share Analysis, by Company, 2018 (Estimated)
目次

Title:
Prostate Cancer Therapeutics Market (Therapy: Hormone Therapy, Chemotherapy, Biologic Therapy, and Targeted Therapy; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027.

Scope of the Study

[206 Pages Report] Transparency Market Research (PMR) carried out a comprehensive analysis measuring the growth potential of the prostate cancer therapeutics market in its latest research report for the forecast period of 2019-2027. The business study encompasses some key insights for market players that can help them upkeep their position and consolidate their share in the market.

The research report intends to offer rare and distinguished information apropos of the growth of the prostate cancer therapeutics market, and brings to the fore the latent growth opportunities for market players. With the help of the insights found by this research, stakeholders operating in the prostate cancer therapeutics market will gain an incisive outlook pertaining to the growth trajectory, which can help them in making sustainable strategies for their business growth.

This exclusive business study consists of an incisive outlook regarding the evolution of the prostate cancer therapeutics market and changing dynamics during the course of the forecast period of 2019-2027. This exclusive business study provides information regarding the crucial drivers, threats, opportunities, and trends available in the prostate cancer therapeutics market, in order to equip stakeholders with the most recent developments and market shifts.

This detailed research report also covers a comprehensive SWOT analysis of the leading, prominent, and emerging market players functioning in the prostate cancer therapeutics market. This will aid stakeholders achieve an incisive outlook pertaining to the growth of the prostate cancer therapeutics market.

This exclusive guide analyzes and discusses Porter's Five Forces to offer key growth strategies available in the prostate cancer therapeutics market during the forecast period. This comprehensive guide offers significant information about the competition present in the prostate cancer therapeutics market by determining key competitors. The exclusive report also includes key strategies, financials, and notable developments present in the prostate cancer therapeutics market during the forecast period of 2019-2027.

Segmentation

In order to present an incisive view of the prostate cancer therapeutics market, analysts and researchers of the report have segregated the prostate cancer therapeutics market on the basis of therapy, distribution channel, and region. This comprehensive business study also analyzes the incremental opportunity present in the prostate cancer therapeutics market during the forecast period.

Key Questions Answered:

The report on the prostate cancer therapeutics market answers key concerns encircling the growth of the market.

  • What are the recent developments and market shifts observed in the prostate cancer therapeutics market?
  • What are the key winning imperatives for leading and prominent players functioning in the prostate cancer therapeutics market?
  • What are the significant trends stimulating the growth of the prostate cancer therapeutics market?
  • Which end-use industry will exert strong influence on the prostate cancer therapeutics market?

Research Methodology

The research report conducted by Transparency Market Research (TMR) analysts consists of a systematic methodology, employed with a view to cull key insights pertaining to the growth of the prostate cancer therapeutics market during the forecast period of 2019-2027. Discussions with opinion leaders, market heads, vendors, distributors, industry experts, and key players were conducted in order to conduct primary research. In addition to this, our analysts also carried out a thorough secondary study of marketing collaterals, industry associations, company websites, and government statistics.

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Research Methodology

  • 2.1. Assumptions
  • 2.2. Research Methodology

3. Executive Summary

  • 3.1. Global Prostate Cancer Therapeutics Market Snapshot, 2018

4. Market Overview

  • 4.1. Therapy Overview
  • 4.2. Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2017-2027
  • 4.3. Global Prostate Cancer Therapeutics Market Outlook
  • 4.4. Global Prostate Cancer Therapeutics Market : Key Industry Events
  • 4.5. Global Prostate Cancer Therapeutics Market : Pipeline Analysis
  • 4.6. Global Disease Prevalence & Incidence
  • 4.7. Overall Prostate Cancer (2017-2027)
  • 4.8. By Clinical Stages (2018)

5. Market Dynamics

  • 5.1. Drivers
    • 5.1.1. Increasing prevalence of prostate cancer
    • 5.1.2. Launch of promising emerging therapies
    • 5.1.3. Innovation in the development of new drugs and therapeutic biological products
    • 5.1.4. High growth in hormone-refractory prostate cancer drug due to lesser side effects
  • 5.2. Restrains
    • 5.2.1. High cost of treatment
    • 5.2.2. Reluctance toward adoption of premium treatments
  • 5.3. Opportunities
    • 5.3.1. Large undiagnosed patient population
    • 5.3.2. Rise in funding from both public and private sector in the field of drug development
  • 5.4. Key Trends
    • 5.4.1. Increasing application of biotechnology in anticancer drugs development
    • 5.4.2. New drugs entering the market with higher costs
    • 5.4.3. Oral drugs account for a large share of the oncology drugs market

6. Global Prostate Cancer Therapeutics Market Analysis, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
  • 6.3. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Therapy
  • 6.4. Prostate Cancer Therapeutics Market Analysis, by Therapy
    • 6.4.1. Hormone Therapy
      • 6.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
      • 6.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
      • 6.4.1.3. Antiandrogens
    • 6.4.2. Chemotherapy
      • 6.4.2.1. Systemic Chemotherapy
      • 6.4.2.2. Regional Chemotherapy
    • 6.4.3. Biologic Therapy
    • 6.4.4. Targeted Therapy
  • 6.5. Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2019-2027
  • 6.6. Key Trends

7. Global Prostate Cancer Therapeutics Market Analysis, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
  • 7.3. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Distribution Channel
  • 7.4. Prostate Cancer Therapeutics Market Analysis, by Distribution Channel
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Online Sales
    • 7.4.4. Others
  • 7.5. Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2019-2027
  • 7.6. Key Trends

8. Global Prostate Cancer Therapeutics Market Analysis, by Region

  • 8.1. Global Prostate Cancer Therapeutics Market Snapshot, by Country
  • 8.2. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Region
  • 8.3. Prostate Cancer Therapeutics Market Forecast, by Region
  • 8.4. Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2019-2027

9. North America Prostate Cancer Therapeutics Market Analysis

  • 9.1. Market Outlook
  • 9.2. North America Prostate Cancer Therapeutics Market Overview
  • 9.3. North America Market Value Share Analysis, by Therapy
  • 9.4. North America Market Forecast, by Therapy
    • 9.4.1. Hormone Therapy
      • 9.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
      • 9.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
      • 9.4.1.3. Antiandrogens
    • 9.4.2. Chemotherapy
      • 9.4.2.1. Systemic Chemotherapy
      • 9.4.2.2. Regional Chemotherapy
    • 9.4.3. Biologic Therapy
    • 9.4.4. Targeted Therapy
  • 9.5. North America Market Value Share Analysis, by Distribution Channel
  • 9.6. North America Market Forecast, by Distribution Channel
    • 9.6.1. Hospital Pharmacy
    • 9.6.2. Retail Pharmacy
    • 9.6.3. Online Sales
    • 9.6.4. Others
  • 9.7. Market Analysis, by Country
  • 9.8. Market Value Share Analysis, by Country
  • 9.9. Market Size (US$ Mn) Forecast, by Country, 2019-2027
    • 9.9.1. U.S.
    • 9.9.2. Canada
  • 9.10. Market Attractiveness Analysis
    • 9.10.1. By Therapy
    • 9.10.2. By Distribution Channel
    • 9.10.3. By Country
  • 9.11. Market Trends

10. Europe Prostate Cancer Therapeutics Market Analysis

  • 10.1. Market Outlook
  • 10.2. Europe Prostate Cancer Therapeutics Market Overview
  • 10.3. Europe Market Value Share Analysis, by Therapy
  • 10.4. Europe Market Forecast, by Therapy
    • 10.4.1. Hormone Therapy
      • 10.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
      • 10.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
      • 10.4.1.3. Antiandrogens
    • 10.4.2. Chemotherapy
      • 10.4.2.1. Systemic Chemotherapy
      • 10.4.2.2. Regional Chemotherapy
    • 10.4.3. Biologic Therapy
    • 10.4.4. Targeted Therapy
  • 10.5. Europe Market Value Share Analysis, by Distribution Channel
  • 10.6. Europe Market Forecast, by Distribution Channel
    • 10.6.1. Hospital Pharmacy
    • 10.6.2. Retail Pharmacy
    • 10.6.3. Online Sales
    • 10.6.4. Others
  • 10.7. Market Analysis, by Country/Sub-region
  • 10.8. Market Value Share Analysis, by Country/Sub-region
  • 10.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
    • 10.9.1. U.K.
    • 10.9.2. Germany
    • 10.9.3. Italy
    • 10.9.4. France
    • 10.9.5. Spain
    • 10.9.6. Russia
    • 10.9.7. Rest of Europe
  • 10.10. Market Attractiveness Analysis
    • 10.10.1. By Therapy
    • 10.10.2. By Distribution Channel
    • 10.10.3. By Country/Sub-region
  • 10.11. Market Trends

11. Asia Pacific Prostate Cancer Therapeutics Market Analysis

  • 11.1. Market Outlook
  • 11.2. Asia Pacific Prostate Cancer Therapeutics Market Overview
  • 11.3. Asia Pacific Market Value Share Analysis, by Therapy
  • 11.4. Asia Pacific Market Forecast, by Therapy
    • 11.4.1. Hormone Therapy
      • 11.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
      • 11.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
      • 11.4.1.3. Antiandrogens
    • 11.4.2. Chemotherapy
      • 11.4.2.1. Systemic Chemotherapy
      • 11.4.2.2. Regional Chemotherapy
    • 11.4.3. Biologic Therapy
    • 11.4.4. Targeted Therapy
  • 11.5. Asia Pacific Market Value Share Analysis, by Distribution Channel
  • 11.6. Asia Pacific Market Forecast, by Distribution Channel
    • 11.6.1. Hospital Pharmacy
    • 11.6.2. Retail Pharmacy
    • 11.6.3. Online Sales
    • 11.6.4. Others
  • 11.7. Market Analysis, by Country/Sub-region
  • 11.8. Market Value Share Analysis, by Country/Sub-region
  • 11.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
    • 11.9.1. China
    • 11.9.2. Japan
    • 11.9.3. India
    • 11.9.4. Australia & New Zealand
    • 11.9.5. Rest of Asia Pacific
  • 11.10. Market Attractiveness Analysis
    • 11.10.1. By Therapy
    • 11.10.2. By Distribution Channel
    • 11.10.3. By Country/Sub-region
  • 11.11. Market Trends

12. Latin America Prostate Cancer Therapeutics Market Analysis

  • 12.1. Market Outlook
  • 12.2. Latin America Prostate Cancer Therapeutics Market Overview
  • 12.3. Latin America Market Value Share Analysis, by Therapy
  • 12.4. Latin America Market Forecast, by Therapy
    • 12.4.1. Hormone Therapy
      • 12.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
      • 12.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
      • 12.4.1.3. Antiandrogens
    • 12.4.2. Chemotherapy
      • 12.4.2.1. Systemic Chemotherapy
      • 12.4.2.2. Regional Chemotherapy
    • 12.4.3. Biologic Therapy
    • 12.4.4. Targeted Therapy
  • 12.5. Latin America Market Value Share Analysis, by Distribution Channel
  • 12.6. Latin America Market Forecast, by Distribution Channel
    • 12.6.1. Hospital Pharmacy
    • 12.6.2. Retail Pharmacy
    • 12.6.3. Online Sales
    • 12.6.4. Others
  • 12.7. Market Analysis, by Country/Sub-region
  • 12.8. Market Value Share Analysis, by Country/Sub-region
  • 12.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
    • 12.9.1. Brazil
    • 12.9.2. Mexico
    • 12.9.3. Rest of Latin America
  • 12.10. Market Attractiveness Analysis
    • 12.10.1. By Therapy
    • 12.10.2. By Distribution Channel
    • 12.10.3. By Country/Sub-region
  • 12.11. Market Trends

13. Middle East & Africa Prostate Cancer Therapeutics Market Analysis

  • 13.1. Market Outlook
  • 13.2. Middle East & Africa Prostate Cancer Therapeutics Market Overview
  • 13.3. Middle East & Africa Market Value Share Analysis, by Therapy
  • 13.4. Middle East & Africa Market Forecast, by Therapy
    • 13.4.1. Hormone Therapy
      • 13.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
      • 13.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
      • 13.4.1.3. Antiandrogens
    • 13.4.2. Chemotherapy
      • 13.4.2.1. Systemic Chemotherapy
      • 13.4.2.2. Regional Chemotherapy
    • 13.4.3. Biologic Therapy
    • 13.4.4. Targeted Therapy
  • 13.5. Middle East & Africa Market Value Share Analysis, by Distribution Channel
  • 13.6. Middle East & Africa Market Forecast, by Distribution Channel
    • 13.6.1. Hospital Pharmacy
    • 13.6.2. Retail Pharmacy
    • 13.6.3. Online Sales
    • 13.6.4. Others
  • 13.7. Market Analysis, by Country/Sub-region
  • 13.8. Market Value Share Analysis, by Country/Sub-region
  • 13.9. Market Size (US$ Mn) Forecast, by Country/Sub-region, 2019-2027
    • 13.9.1. Saudi Arabia
    • 13.9.2. South Africa
    • 13.9.3. UAE
    • 13.9.4. Rest of Middle East & Africa
  • 13.10. Market Attractiveness Analysis
    • 13.10.1. By Therapy
    • 13.10.2. By Distribution Channel
    • 13.10.3. By Country
  • 13.11. Market Trends

14. Company Profiles

  • 14.1. Prostate Cancer Therapeutics Market Share Analysis, by Company, 2018 (Estimated)
  • 14.2. Competition Matrix
  • 14.3. Company Profiles
    • 14.3.1. Amgen, Inc.
    • 14.3.2. Johnson & Johnson (Janssen Biotech, Inc.)
    • 14.3.3. Pfizer, Inc.
    • 14.3.4. AstraZeneca
    • 14.3.5. AbbVie, Inc.
    • 14.3.6. Bayer AG
    • 14.3.7. Ipsen Group
    • 14.3.8. Sanofi
    • 14.3.9. Endo Pharmaceuticals, Inc.
    • 14.3.10. Dendreon Corporation (Sanpower Group Co. Ltd.)